News on Relapsing_Fever from BioPortfolio.com http://www.BioPortfolio.com Consolidated Relapsing_Fever news from BioPortfolio.com Wed, 10 Feb 2010 10:05:44 GMT en A Placebo-Controlled Trial of Oral Fingolimod in Relapsing Multiple Sclerosishttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4019686&HITNO=0&MSIZE=21&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Relapsing_Fever&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4019686&THISHREF=http://c.moreover.com/click/here.pl%3fz2526437950%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4019686&HITNO=0&MSIZE=21&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Relapsing_Fever&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4019686&THISHREF=http://c.moreover.com/click/here.pl%3fz2526437950%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comMDLinx: A Placebo-Controlled Trial of Oral Cladribine for Relapsing Multiple Sclerosishttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4019682&HITNO=1&MSIZE=21&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Relapsing_Fever&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4019682&THISHREF=http://c.moreover.com/click/here.pl%3fz2526437242%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4019682&HITNO=1&MSIZE=21&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Relapsing_Fever&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4019682&THISHREF=http://c.moreover.com/click/here.pl%3fz2526437242%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comMDLinx: Oral Fingolimod or Intramuscular Interferon for Relapsing Multiple Sclerosishttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4019681&HITNO=2&MSIZE=21&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Relapsing_Fever&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4019681&THISHREF=http://c.moreover.com/click/here.pl%3fz2526437174%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4019681&HITNO=2&MSIZE=21&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Relapsing_Fever&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4019681&THISHREF=http://c.moreover.com/click/here.pl%3fz2526437174%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comMDLinx: A Placebo-Controlled Trial of Oral Fingolimod in Relapsing Multiple Sclerosishttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4013447&HITNO=3&MSIZE=21&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Relapsing_Fever&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4013447&THISHREF=http://c.moreover.com/click/here.pl%3fz2523722064%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4013447&HITNO=3&MSIZE=21&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Relapsing_Fever&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4013447&THISHREF=http://c.moreover.com/click/here.pl%3fz2523722064%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comNew England Journal of Medicine: Oral Fingolimod or Intramuscular Interferon for Relapsing Multiple Sclerosishttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4013445&HITNO=4&MSIZE=21&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Relapsing_Fever&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4013445&THISHREF=http://c.moreover.com/click/here.pl%3fz2523721642%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4013445&HITNO=4&MSIZE=21&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Relapsing_Fever&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4013445&THISHREF=http://c.moreover.com/click/here.pl%3fz2523721642%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comNew England Journal of Medicine: A Placebo-Controlled Trial of Oral Cladribine for Relapsing Multiple Sclerosishttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4013444&HITNO=5&MSIZE=21&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Relapsing_Fever&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4013444&THISHREF=http://c.moreover.com/click/here.pl%3fz2523721248%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4013444&HITNO=5&MSIZE=21&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Relapsing_Fever&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4013444&THISHREF=http://c.moreover.com/click/here.pl%3fz2523721248%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comNew England Journal of Medicine: Re-Challenge Chemo May up Survival in Relapsing Non-Small-Cell Lung Cancerhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3985244&HITNO=6&MSIZE=21&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Relapsing_Fever&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3985244&THISHREF=http://c.moreover.com/click/here.pl%3fz2508522460%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3985244&HITNO=6&MSIZE=21&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Relapsing_Fever&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3985244&THISHREF=http://c.moreover.com/click/here.pl%3fz2508522460%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comAbstracts in Hematology and Oncology: Re-Challenge Chemo May up Survival in Relapsing Non-Small-Cell Lung Cancerhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3984639&HITNO=7&MSIZE=21&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Relapsing_Fever&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3984639&THISHREF=http://c.moreover.com/click/here.pl%3fz2508249522%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3984639&HITNO=7&MSIZE=21&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Relapsing_Fever&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3984639&THISHREF=http://c.moreover.com/click/here.pl%3fz2508249522%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comGeneral Medicine eJournal: Re-Challenge Chemo May up Survival in Relapsing Non-Small-Cell Lung Cancerhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3984424&HITNO=8&MSIZE=21&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Relapsing_Fever&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3984424&THISHREF=http://c.moreover.com/click/here.pl%3fz2508160407%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3984424&HITNO=8&MSIZE=21&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Relapsing_Fever&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3984424&THISHREF=http://c.moreover.com/click/here.pl%3fz2508160407%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comMedscape: Advantage of MIDAM Protocol in Treatment of the Elderly Patients With Refractory and Relapsing Acute Myeloid Lhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3981085&HITNO=9&MSIZE=21&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Relapsing_Fever&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3981085&THISHREF=http://c.moreover.com/click/here.pl%3fz2506767149%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3981085&HITNO=9&MSIZE=21&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Relapsing_Fever&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3981085&THISHREF=http://c.moreover.com/click/here.pl%3fz2506767149%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comJournal of Clinical Oncology: Oral Fingolimod or Intramuscular Interferon for Relapsing Multiple Sclerosishttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3957581&HITNO=10&MSIZE=21&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Relapsing_Fever&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3957581&THISHREF=http://c.moreover.com/click/here.pl%3fz2495011365%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3957581&HITNO=10&MSIZE=21&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Relapsing_Fever&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3957581&THISHREF=http://c.moreover.com/click/here.pl%3fz2495011365%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comDoctors Guide: A Placebo-Controlled Trial of Oral Cladribine for Relapsing Multiple Sclerosishttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3957411&HITNO=11&MSIZE=21&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Relapsing_Fever&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3957411&THISHREF=http://c.moreover.com/click/here.pl%3fz2494941041%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3957411&HITNO=11&MSIZE=21&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Relapsing_Fever&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3957411&THISHREF=http://c.moreover.com/click/here.pl%3fz2494941041%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comDoctors Guide: A Placebo-Controlled Trial of Oral Fingolimod in Relapsing Multiple Sclerosishttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3957399&HITNO=12&MSIZE=21&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Relapsing_Fever&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3957399&THISHREF=http://c.moreover.com/click/here.pl%3fz2494939031%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3957399&HITNO=12&MSIZE=21&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Relapsing_Fever&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3957399&THISHREF=http://c.moreover.com/click/here.pl%3fz2494939031%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comDoctors Guide: Two-Year Results From CLARITY Study with Cladribine Tablets in Multiple Sclerosis Published in The New England Journal of Medicinehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3947194&HITNO=13&MSIZE=21&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Relapsing_Fever&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3947194&THISHREF=http://c.moreover.com/click/here.pl%3fz2487915400%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3947194&HITNO=13&MSIZE=21&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Relapsing_Fever&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3947194&THISHREF=http://c.moreover.com/click/here.pl%3fz2487915400%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comcompaniesandmarkets.com: Novartis oral MS therapy FTY720 shows reduced risk of confirmed disability progression as published in New Enghttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3940824&HITNO=14&MSIZE=21&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Relapsing_Fever&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3940824&THISHREF=http://c.moreover.com/click/here.pl%3fz2485223715%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3940824&HITNO=14&MSIZE=21&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Relapsing_Fever&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3940824&THISHREF=http://c.moreover.com/click/here.pl%3fz2485223715%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comCanada NewsWire: